genOway
Designs and develops genetically modified preclinical models for research.
ALGEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0004053510
- LEI:
- 969500HMHUPR3KYXUT19
- Country:
- France
- Address:
- 31 RUE SAINT JEAN DE DIEU, 69007 LYON
- Website:
- https://www.genoway.com
Description
genOway is a biotechnology company that specializes in designing and developing genetically modified preclinical models. It provides biopharmaceutical companies and academic researchers with genetically engineered mouse, rat, and cell line models intended to improve the predictability of preclinical research. The company's portfolio includes a catalog of off-the-shelf models as well as customized model creation services. Key areas of application for its models include immuno-oncology and pharmacokinetic (PK) analysis, featuring a range of humanized models. genOway emphasizes a collaborative approach, providing scientifically validated solutions to support the development of new therapies for clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-02-24 18:00 |
Délivrance d'un 1er brevet américain pour la technologie SMASh dont genOway a a…
|
French | 133.3 KB | ||
| 2020-01-28 07:30 |
genOway réalise une levée de fonds de 6,2 M EUR pour accompagner sa nouvelle st…
|
French | 274.1 KB | ||
| 2020-01-15 18:20 |
genOway Chiffre d'affaires 2019
|
French | 170.3 KB | ||
| 2020-01-13 18:15 |
genOway signe un contrat stratégique pour la distribution de ses modèles catalo…
|
French | 116.0 KB | ||
| 2019-09-23 18:30 |
Résultats financiers au 30 juin 2019
|
French | 387.7 KB | ||
| 2019-03-28 19:06 |
Résultats Financiers au 31 décembre 2018
|
French | 195.2 KB | ||
| 2019-01-21 18:30 |
genOway Chiffre d'affaires 2018
|
French | 177.2 KB | ||
| 2018-12-10 21:11 |
genOway et Merck signent une alliance stratégique sur la technologie CRISPR/Cas…
|
French | 154.2 KB | ||
| 2018-01-09 15:19 |
Bilan semestriel du contrat de liquidité - Décembre 2017
|
French | 88.7 KB | ||
| 2017-07-05 10:00 |
Bilan semestriel du contrat de liquidité - Juin 2017
|
French | 203.1 KB | ||
| 2016-09-12 19:15 |
Résultats Financiers au 30 juin 2016
|
French | 342.6 KB | ||
| 2016-07-12 18:45 |
genOway : Chiffre d’affaires du 1er semestre 2016
|
French | 411.1 KB | ||
| 2016-02-29 17:45 |
Résultats Financiers au 31 décembre 2015
|
French | 272.6 KB | ||
| 2015-10-01 18:45 |
Résultats Financiers au 30 juin 2015
|
French | 129.7 KB | ||
| 2015-03-16 17:45 |
Résultats Financiers au 31 décembre 2014
|
French | 336.0 KB |
Automate Your Workflow. Get a real-time feed of all genOway filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for genOway
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for genOway via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-17 | N/A | Other | Sell | 1,700 | 8,160.00 EUR |
| 2023-12-15 | N/A | Other | Sell | 5,000 | 22,000.00 EUR |
| 2023-11-23 | N/A | Other | Sell | 500 | 2,100.00 EUR |
| 2023-10-23 | N/A | Other | Sell | 100 | 390.00 EUR |
| 2023-09-25 | N/A | Other | Buy | 5,000 | 20,000.00 EUR |
| 2023-05-04 | N/A | Other | Buy | 60,000 | 222,000.00 EUR |
| 2023-05-02 | N/A | Other | Sell | 20,000 | 74,000.00 EUR |
Peer Companies
